Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma

Journal of Pathology

Volumn 181, Issue 1, 1997, Pages 8-13

  Dei Tos, Angelo P ^e   Doglioni, Claudio ^a,f   Piccinin, Sara ^c   Maestro, Roberta ^c   Mentzel, Thomas ^d   Barbareschi, Mattia ^b   Boiocchi, Mauro ^c   Fletcher, Christopher D M ^e  

^a Departments of Pathology   (Italy)

^b Departments of Pathology   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d Institute of Pathology   (Germany)

^e HARVARD MEDICAL SCHOOL   (United States)

^f Department of Pathology   (Italy)

Author keywords

cell cycle regulators; dedifferentiated liposarcoma; dedifferentiation; liposarcoma; mdm2; p53

Indexed keywords

PROTEIN P21; PROTEIN P53;

ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOFT TISSUE SARCOMA;

EID: 0031038770     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9896(199701)181:1<8::aid-path700>3.0.co;2-%23     Document Type: Article

References (30)

1. Weiss SW (ed.), Histologic Typing of Soft Tissue Tumours. World Health Organization Histological Classification of Tumours. Berlin: Springer-Verlag. 1994.
2. Dei Tos AP, Mentzel T, Newman PL, Fletcher CDM. Spindle cell liposarcoma: a hitherto unrecognized variant of well-differentiated liposarcoma: analysis of six cases. Am J Surg Pathol 1994; 18: 913 921.
3. Evans HL. Liposarcoma. A study of 55 cases with reassessment of its classification. Am J Surg Pathol 1979; 3: 507 523.
4. Weiss SW, Rao VK. Well differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of 'dedifferentiation'. Am J Surg Pathol 1992; 16: 1051-1058.
5. Leach SL, Tokino T, Meltzer P, et al. p53 mutation and mdm2 amplification in soft tissue sarcomas. Cancer Res 1993; 53: 2231-2234.
6. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 58: 80-86.
7. Goldblum JR, Frank TS, Poy EL, Weiss SW. p53 mutations and tumour progression in well-differentiated liposarcoma and dermatofibrosarcoma protuberans. Int J Surg Pathol 1995; 3: 35-42.
8. Fletcher CDM. Author's reply. Am J Surg Pathol 1995; 19: 1216-1217.
9. McCormick D, Mentzel T, Beham A, Fletcher CDM. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol 1994; 18: 1213-1223.
10. Maestro R, Dolcetti R, Gasparotto D, et al. High frequency of p53 alterations associated with overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992; 7: 1159-1166.
11. Marchetti A, Buttitta F, Girlando S, et al. mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J Pathol 1995; 175: 31-38.
12. waf1/Cip1 expression in normal mucosa, adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol 1996; 179: 248-253.
13. Dei Tos AP, Maestro R, Doglioni C, et al. Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 1994; 145: 11-17.
14. Greenblatt MS, Benett WP, Hollstein M, Harris CC. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878.
15. Andreassen A, Oyord T, Hovig E, et al. p53 abnormalities in different subtypes of human sarcomas. Cancer Res 1993; 53: 468-471.
16. Cordon-Cardo C, Latres E, Drobnjak M, et al. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994; 54: 794-799.
17. Foti A, Ahuja HG, Koduru AP, et al. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis. Blood 1991; 11: 2441-2444.
18. Sidransky D, Mikkelsen T, Schweichemer K, Rosemblum ML, Cavanee W, Vogelstein B. Clonal expression of p53 mutant cells is associated with brain tumour progression. Nature 1992; 355: 846-847.
19. Ito T, Seyama T, Mizuno T, et al. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 1992; 52: 1369-1371.
20. Dei Tos AP, Doglioni C, Laurino L, Barbareschi M, Fletcher CDM. p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopathology 1993; 22: 45-50.
21. Dei Tos AP, Maestro R, Doglioni C, et al. Tumour suppressor genes and related molecules in leiomyosarcoma. Am J Pathol 1996; 148: 1037 1045.
22. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WH, Givol D. Induction of WAF1/CIP1 by a p53 independent pathway. Cancer Res 1994; 54: 3391 3395.
23. Maestro R, Gloghini A, Doglioni C, et al. mdm2 overexpression does not account for stabilization of wild type p53 protein in non-Hodgkin lymphomas. Blood 1995; 11: 3239 3246.
24. Xiao Z-X, Chen J, Levine AJ, et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 1995; 375: 694-697.
25. Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T. Stimulation of E2F1/DP1 transcriptional activity by mdm2 oncoprotein. Nature 1995; 375: 691-694.
26. Nakayama T, Toguchida L, Wadayama B, Kanohe H, Kotoura Y, Sasaki MS. mdm2 gene amplification in bone and soft tissue tumours: association with tumour progression in differentiated adipose tissue tumours. Int J Cancer 1995; 64: 342-346.
27. Dal Cin P, Kools P, Sciot R, et al. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumours. Cancer Genet Cytogenet 1993; 68: 85-90.
28. Fletcher CDM, Akerman M, Dal Cin P, et al. Correlation between clinicopathologic features and karyotype in lipomatous tumours. A report from 178 cases from the CHromosomes And MorPhology (CHAMP) collaborative study group. Am J Pathol 1996; 148: 623-630.
29. Mentzel T, Fletcher CDM. Lipomatous tumour of the soft tissues: an update. Virchows Arch 1995; 427: 353-363.
30. Dowell SP, Hall PA. The p53 tumour suppressor gene and tumour prognosis: is there a relationship? J Pathol 1995; 177: 221-224.